[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644466":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":68,"collaborators":20,"id":71,"slug":20,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":77,"sex":78,"minAge":79,"maxAge":20,"enrollmentInfo":80,"targetDuration":20,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":50,"whyStopped":20,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Study Participants","EXPERIMENTAL","Study participants will be persons who have late period of up to 21 days",[13],"Drug: Mifepristone + Misoprostol",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Mifepristone + Misoprostol","Study participants are given mifepristone and misoprostol for menstrual regulation.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Ushma D Upadhyay, PhD, MPH","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","415-353-4626","ushma.upadhyay@ucsf.edu",{"name":31,"role":27,"phone":32,"phoneExt":20,"email":33},"Jennifer Ko, MLIS","415-353-9113","jennifer.ko@ucsf.edu",[35,48],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":20},"UCSF Advancing New Standards in Reproductive Health (ANSIRH)","ACTIVE_NOT_RECRUITING","Oakland","California","94612","United States",{"type":43,"coordinates":44},"Point",[45,46],-122.2708,37.80437,{"lat":46,"lon":45},{"facility":49,"status":50,"city":51,"state":52,"zip":53,"country":41,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Roanoke Health Center","RECRUITING","Roanoke","Virginia","24017",{"type":43,"coordinates":55},[56,57],-79.94143,37.27097,{"lat":57,"lon":56},[60,64],{"name":61,"role":27,"phone":62,"phoneExt":20,"email":63},"Christine Hernández, MPH, MPM, CPHQ","828-280-5723","christina.hernandez@ppsat.org",{"name":65,"role":27,"phone":66,"phoneExt":20,"email":67},"Matthew Zerden, MD, MPH","617-935-2394","matthew.zerden@ppsat.org",{"type":24,"investigatorFullName":69,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Ushma Upadhyay","Principal Investigator","100644466",false,"NCT07671989","Period Pills for Menstrual Regulation: A New Reproductive Health Option","Period Pills","Inclusion Criteria:\n\n* Be 18 years old or older\n* Read and speak English\n* Know the date of their last menstrual period within 2 days\n* Have a period that is late by up to 21 days\n* Must have had regular periods in the last 4 months\n* Does not want to be pregnant\n* Does not want to verify pregnancy status\n* Understand that if they are pregnant, the pills will end their pregnancy\n* Does not have contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone\u002Fmisoprostol\u002Fprostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)\n\nExclusion Criteria:\n\n* Under 18 years old\n* Does not read and speak English\n* Does not know the date of their last menstrual period within 2 days\n* Has not had regular periods in the last 4 months\n* Wants to be pregnant\n* Wants to verify pregnancy status\n* Does not display understanding that if they are pregnant, the pills will end their pregnancy\n* Has any contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone\u002Fmisoprostol\u002Fprostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)",true,"FEMALE","18 Years",{"count":81,"type":82},100,"ESTIMATED","INTERVENTIONAL",[85],"PHASE4","The Period Pills Study is a prospective observational study among people who decide to use a combination of mifepristone and misoprostol for menstrual regulation.",[88,89],"Menstrual Regulation","Menstrual Health Intervention",[91,92,93],"late period","missed period","mestruation","2026-06-22",{"date":96,"type":97},"2026-06-26","ACTUAL",{"date":94,"type":97},{"date":100,"type":82},"2027-05-31",{"name":5,"class":6},2]